ti.\*:("Pharmacopathogenesis")
Results 1 to 8 of 8
Selection :
PharmacopathogenesisBREEDVELD, Ferry; BROOKS, Peter.Baillière's best practice & research. Clinical rheumatology. 2001, Vol 15, Num 5, issn 1521-6942, 196 p.Serial Issue
Transcription factorsHANDEL, Malcolm L; GIRGIS, Laila.Baillière's best practice & research. Clinical rheumatology. 2001, Vol 15, Num 5, pp 657-675, issn 1521-6942Article
Vascular mechanisms in osteoarthritisGHOSH, Peter; CHERAS, Phillip A.Baillière's best practice & research. Clinical rheumatology. 2001, Vol 15, Num 5, pp 693-709, issn 1521-6942Article
Metalloproteases and inhibitors in arthritic diseasesMARTEL-PELLETIER, Johanne; WELSCH, Dean J; PELLETIER, Jean-Pierre et al.Baillière's best practice & research. Clinical rheumatology. 2001, Vol 15, Num 5, pp 805-829, issn 1521-6942Article
The role of nitric oxide in tissue destructionABRAMSON, Steven B; AMIN, Ashok R; CLANCY, Robert M et al.Baillière's best practice & research. Clinical rheumatology. 2001, Vol 15, Num 5, pp 831-845, issn 1521-6942Article
Osteoporosis: pathophysiology and non-pharmacological managementMUNDY, Gregory R.Baillière's best practice & research. Clinical rheumatology. 2001, Vol 15, Num 5, pp 727-745, issn 1521-6942Article
Skeletal tissue engineering: opportunities and challengesLUYTEN, Frank P; DELL'ACCIO, Francesco; DE BARI, Cosimo et al.Baillière's best practice & research. Clinical rheumatology. 2001, Vol 15, Num 5, pp 759-769, issn 1521-6942Article
Stem cells in the aetiopathogenesis and therapy of rheumatic diseaseMOORE, John; TYNDALL, Alan; BROOKS, Peter et al.Baillière's best practice & research. Clinical rheumatology. 2001, Vol 15, Num 5, pp 711-726, issn 1521-6942Article